Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers. Elbehi AM, Anu RI, Ekine-Afolabi B, Cash E, et al. Oral Oncol 2020;109:104977.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elbehi AM, Anu RI, Ekine-Afolabi B, Cash E, et al. Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers. Oral Oncol 2020;109:104977.
PMID: 32853912